Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study.

Lakoh S, Jiba DF, Kanu JE, Poveda E, Salgado-Barreira A, Sahr F, Sesay M, Deen GF, Sesay T, Gashau W, Salata RA, Yendewa GA.

BMC Public Health. 2019 Oct 21;19(1):1320. doi: 10.1186/s12889-019-7614-3.

2.

A two-part phase I study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonization of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation.

Yendewa GA, Griffiss JM, Jacobs MR, Fulton SA, O'Riordan MA, Gray WA, Proskin HM, Winkle P, Salata RA.

J Glob Antimicrob Resist. 2019 Oct 7. pii: S2213-7165(19)30250-4. doi: 10.1016/j.jgar.2019.09.017. [Epub ahead of print]

PMID:
31600598
3.

Development and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma.

Gray WA, Waldorf B, Rao MG, Stiles BL, Griffiss JM, Salata RA, Blumer JL.

J Pharm Biomed Anal. 2019 Nov 30;176:112775. doi: 10.1016/j.jpba.2019.07.023. Epub 2019 Aug 16.

PMID:
31446299
4.

The Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections.

Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, Harris A, Napravnik S, van Duin D.

Clin Infect Dis. 2019 Jun 19. pii: ciz528. doi: 10.1093/cid/ciz528. [Epub ahead of print]

PMID:
31219148
5.

Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.

Yendewa GA, Sahr F, Lakoh S, Ruiz M, Patiño L, Tabernilla A, Deen GF, Sesay M, Salata RA, Poveda E.

J Antimicrob Chemother. 2019 Jul 1;74(7):2024-2029. doi: 10.1093/jac/dkz134.

6.

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone.

Yendewa GA, Sahr F, Aguilera A, Lakoh S, Sesay M, Deen GF, Patiño L, Poveda E, Salata RA.

Am J Trop Med Hyg. 2019 Jun;100(6):1521-1524. doi: 10.4269/ajtmh.18-1001.

PMID:
30938283
7.

ADDRESSING PITFALLS IN MANAGEMENT OF DIABETIC KETOACIDOSIS WITH A STANDARDIZED PROTOCOL.

Karajgikar ND, Manroa P, Acharya R, Codario RA, Reider JA, Donihi AC, Salata RA, Korytkowski MT.

Endocr Pract. 2019 May;25(5):407-412. doi: 10.4158/EP-2018-0398. Epub 2019 Jan 18.

PMID:
30657360
8.

The Effect of an HIV Self-Management Intervention on Neurocognitive Behavioral Processing.

Webel AR, Schreiner N, Salata RA, Friedman J, Jack AI, Sattar A, Fresco DM, Rodriguez M, Moore S.

West J Nurs Res. 2019 Jul;41(7):990-1008. doi: 10.1177/0193945918823347. Epub 2019 Jan 17.

PMID:
30654713
9.

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D.

Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.

10.

Effects of Rifamycin Coadministration on Bedaquiline Desmethylation in Healthy Adult Volunteers.

Healan AM, Salata RA, Griffiss JM, Proskin HM, O'Riordan MA, Gray WA, Blumer JL.

Clin Pharmacol Drug Dev. 2019 May;8(4):436-442. doi: 10.1002/cpdd.639. Epub 2018 Nov 30.

PMID:
30500116
11.

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.

Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA, Dezzutti CS, van der Straten A, Hall WB, Jacobson CE, Johnson S, McGowan I, Nel AM, Soto-Torres L, Marzinke MA; MTN-024/IPM 031 Protocol Team for the Microbicide Trials Network .

Clin Infect Dis. 2019 Mar 19;68(7):1144-1151. doi: 10.1093/cid/ciy654.

12.

High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone.

Yendewa GA, Poveda E, Lakoh S, Yendewa SA, Jiba DF, Salgado-Barreira A, Sahr F, Salata RA.

Open Forum Infect Dis. 2018 Aug 23;5(9):ofy208. doi: 10.1093/ofid/ofy208. eCollection 2018 Sep.

13.

Renal infarction in vascular Ehlers-Danlos syndrome masquerading as pyelonephritis.

Dousa KM, Khan K, Alencherry B, Deng L, Salata RA.

Clin Case Rep. 2018 Jun 13;6(8):1478-1480. doi: 10.1002/ccr3.1639. eCollection 2018 Aug.

14.

HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.

Yendewa GA, Poveda E, Yendewa SA, Sahr F, Quiñones-Mateu ME, Salata RA.

AIDS Rev. 2018 Apr-Jun;20(2):104-113. Review.

PMID:
29938704
15.

Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.

Wallis RS, Good CE, O'Riordan MA, Blumer JL, Jacobs MR, Griffiss JM, Healan A, Salata RA.

PLoS One. 2018 May 2;13(5):e0196756. doi: 10.1371/journal.pone.0196756. eCollection 2018.

16.

A Human-Centered Approach to CV Care: Infrastructure Development in Uganda.

Longenecker CT, Kalra A, Okello E, Lwabi P, Omagino JO, Kityo C, Kamya MR, Webel AR, Simon DI, Salata RA, Costa MA.

Glob Heart. 2018 Dec;13(4):347-354. doi: 10.1016/j.gheart.2018.02.002. Epub 2018 Apr 21. Review.

17.

Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine.

Blanchard M, Burton MC, Geraci MW, Madaio MP, Marsh JD, Proweller A, Rockey DC, Salata RA, Tan W, Williams CS, Zaidi M, Todd RF 3rd.

Am J Med. 2018 May;131(5):578-584. doi: 10.1016/j.amjmed.2018.01.015. Epub 2018 Feb 2. No abstract available.

PMID:
29410155
18.

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection.

Klein K, Nickel G, Nankya I, Kyeyune F, Demers K, Ndashimye E, Kwok C, Chen PL, Rwambuya S, Poon A, Munjoma M, Chipato T, Byamugisha J, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

PLoS Pathog. 2018 Jan 18;14(1):e1006754. doi: 10.1371/journal.ppat.1006754. eCollection 2018 Jan.

19.

DISC: Describing Infections of the Spine treated with Ceftaroline.

Watkins RR, Yendewa G, Burdette SD, Horattas S, Haller NA, Mangira C, Salata RA, Bonomo RA.

J Glob Antimicrob Resist. 2018 Jun;13:146-151. doi: 10.1016/j.jgar.2018.01.001. Epub 2018 Jan 11.

PMID:
29337085
20.

Effect of alcohol-based hand rub on hand microbiome and hand skin health in hospitalized adult stem cell transplant patients: A pilot study.

Mukherjee PK, Chandra J, Retuerto M, Arters KA, Consolo MC, Patterson A, Bajaksouzian S, Arbogast JW, Cartner TJ, Jacobs MR, Ghannoum MA, Salata RA.

J Am Acad Dermatol. 2018 Jun;78(6):1218-1221.e5. doi: 10.1016/j.jaad.2017.11.046. Epub 2017 Dec 1. No abstract available.

21.

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.

Gibson RM, Nickel G, Crawford M, Kyeyune F, Venner C, Nankya I, Nabulime E, Ndashimye E, Poon AFY, Salata RA, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ.

Infect Dis Poverty. 2017 Dec 4;6(1):163. doi: 10.1186/s40249-017-0377-0.

22.

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.

Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.

23.

Rheumatic Heart Disease Treatment Cascade in Uganda.

Longenecker CT, Morris SR, Aliku TO, Beaton A, Costa MA, Kamya MR, Kityo C, Lwabi P, Mirembe G, Nampijja D, Rwebembera J, Sable C, Salata RA, Scheel A, Simon DI, Ssinabulya I, Okello E.

Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). pii: e004037. doi: 10.1161/CIRCOUTCOMES.117.004037.

24.

Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.

Healan AM, Griffiss JM, Proskin HM, O'Riordan MA, Gray WA, Salata RA, Blumer JL.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00855-17. doi: 10.1128/AAC.00855-17. Print 2018 Jan.

25.

A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG Jr, Bonomo RA, van Duin D, Kaye KS; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Jul 27;4(3):ofx157. doi: 10.1093/ofid/ofx157. eCollection 2017 Summer.

26.

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Fowler VG Jr, Paterson DL, Bonomo RA, Evans S; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.

27.

Hot News: Ready for HIV Dual Therapy? - New Data from International HIV/AIDS Society 2017.

Yendewa GA, Salata RA.

AIDS Rev. 2017 Oct-Dec;19(3):167-172.

PMID:
29019353
28.

U.S. Physician-Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline.

Salata RA, Geraci MW, Rockey DC, Blanchard M, Brown NJ, Cardinal LJ, Garcia M, Madaio MP, Marsh JD, Todd RF 3rd.

Acad Med. 2018 Apr;93(4):565-573. doi: 10.1097/ACM.0000000000001950.

29.

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH.

Ann Intern Med. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22.

30.

A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection.

Ray AJ, Deshpande A, Fertelli D, Sitzlar BM, Thota P, Sankar C T, Jencson AL, Cadnum JL, Salata RA, Watkins RR, Sethi AK, Carling PC, Wilson BM, Donskey CJ.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):777-783. doi: 10.1017/ice.2017.76. Epub 2017 May 2.

PMID:
28462761
31.

Kidney disease in Uganda: a community based study.

Kalyesubula R, Nankabirwa JI, Ssinabulya I, Siddharthan T, Kayima J, Nakibuuka J, Salata RA, Mondo C, Kamya MR, Hricik D.

BMC Nephrol. 2017 Apr 3;18(1):116. doi: 10.1186/s12882-017-0521-x.

32.

Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.

Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA, Salata RA.

BMC Infect Dis. 2017 Jan 14;17(1):74. doi: 10.1186/s12879-016-2177-8.

33.

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.

Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.

34.

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu A, Frank I, Ho K, Santana J, Stekler JD, McCauley M, Mayer KH.

J Infect Dis. 2017 Jan 15;215(2):238-246. doi: 10.1093/infdis/jiw525.

35.

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.

Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

EBioMedicine. 2016 Nov;13:305-314. doi: 10.1016/j.ebiom.2016.10.014. Epub 2016 Oct 12.

36.

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RA; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Team.

AIDS. 2017 Jan 2;31(1):81-88.

37.

Role of Natural Autoantibodies in Ugandans With Rheumatic Heart Disease and HIV.

Huck DM, Okello E, Mirembe G, Ssinabulya I, Zidar DA, Silverman GJ, Getu L, Nowacki AS, Calabrese LH, Salata RA, Longenecker CT.

EBioMedicine. 2016 Feb 6;5:161-6. doi: 10.1016/j.ebiom.2016.02.006. eCollection 2016 Mar.

38.

The Impact of Mental Wellness on HIV Self-Management.

Webel AR, Sattar A, Schreiner N, Kinley B, Moore SM, Salata RA.

J Assoc Nurses AIDS Care. 2016 Jul-Aug;27(4):468-75. doi: 10.1016/j.jana.2016.03.002. Epub 2016 Mar 23.

39.

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.

Kyeyune F, Gibson RM, Nankya I, Venner C, Metha S, Akao J, Ndashimye E, Kityo CM, Salata RA, Mugyenyi P, Arts EJ, Quiñones-Mateu ME.

Antimicrob Agents Chemother. 2016 May 23;60(6):3380-97. doi: 10.1128/AAC.00038-16. Print 2016 Jun.

40.

Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.

Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D; Antibacterial Resistance Leadership Group.

Clin Microbiol Infect. 2016 Jun;22(6):513-9. doi: 10.1016/j.cmi.2016.01.023. Epub 2016 Feb 3.

41.

Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.

Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Bonomo RA, Fowler VG, van Duin D; Antibacterial Resistance Leadership Group.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):281-8. doi: 10.1017/ice.2015.298. Epub 2015 Dec 21.

42.

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.

AIDS Res Hum Retroviruses. 2016 May;32(5):443-51. doi: 10.1089/AID.2015.0088. Epub 2016 Jan 26.

43.

Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.

Herold BC, Chen BA, Salata RA, Marzinke MA, Kelly CW, Dezzutti CS, McGowan I, Galaska B, Levy L, Piper JM, Hillier S, Hendrix CW.

Clin Infect Dis. 2016 Feb 1;62(3):375-382. doi: 10.1093/cid/civ913. Epub 2015 Oct 27.

44.

Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda.

Gleason B, Mirembe G, Namuyonga J, Okello E, Lwabi P, Lubega I, Lubega S, Musiime V, Kityo C, Salata RA, Longenecker CT.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):196-9. doi: 10.1097/QAI.0000000000000827.

45.

Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe.

Lancaster KE, Kwok C, Rinaldi A, Byamugisha J, Magwali T, Nyamapfeni P, Salata RA, Morrison CS.

Int J Gynaecol Obstet. 2015 Dec;131(3):255-9. doi: 10.1016/j.ijgo.2015.06.035. Epub 2015 Sep 8.

46.

Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.

Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN.

Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.

47.

Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.

van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):942-8. doi: 10.1017/ice.2015.118. Epub 2015 May 20.

48.

An update on the association of vitamin D deficiency with common infectious diseases.

Watkins RR, Lemonovich TL, Salata RA.

Can J Physiol Pharmacol. 2015 May;93(5):363-8. doi: 10.1139/cjpp-2014-0352. Epub 2015 Jan 26. Review.

PMID:
25741906
49.

Evaluation of a pulsed xenon ultraviolet disinfection system for reduction of healthcare-associated pathogens in hospital rooms.

Nerandzic MM, Thota P, Sankar C T, Jencson A, Cadnum JL, Ray AJ, Salata RA, Watkins RR, Donskey CJ.

Infect Control Hosp Epidemiol. 2015 Feb;36(2):192-7. doi: 10.1017/ice.2014.36.

PMID:
25633002
50.

Global medical education partnerships to expand specialty expertise: a case report on building neurology clinical and research capacity.

Kaddumukasa M, Katabira E, Salata RA, Costa MA, Ddumba E, Furlan A, Kakooza-Mwesige A, Kamya MR, Kayima J, Longenecker CT, Mayanja-Kizza H, Mondo C, Moore S, Pundik S, Sewankambo N, Simon DI, Smyth KA, Sajatovic M.

Hum Resour Health. 2014 Dec 30;12:75. doi: 10.1186/1478-4491-12-75.

Supplemental Content

Loading ...
Support Center